oral paste “low dose” - 6.6 mg/g peanut proteins clinical trials

EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX)

This study, called EPOPEX, is looking at how well a special skin patch, Viaskin Peanut, works over a long time to help children with peanut allergy. It checks if the patch continues to reduce their allergic reactions and if it's safe to use for up to three years.